Issued Patents All Time
Showing 1–20 of 20 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12366581 | Methods, compositions, and systems for detecting coronavirus neutralizing antibodies | Mary T. Wrin, Danielle DiTirro | 2025-07-22 |
| 11459624 | Compositions and methods for determining resistance to inhibitors of virus entry using recombinant virus assays | — | 2022-10-04 |
| 10550441 | Compositions and methods for determining resistance to inhibitors of virus entry using recombinant virus assays | — | 2020-02-04 |
| 10358683 | Compositions and methods for determining whether a subject would benefit from co-receptor inhibitor therapy | Wei Huang, Signe Fransen, Jonathan Toma, Jeannette Whitcomb | 2019-07-23 |
| 9841425 | Methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assays | Douglas Richman, Mary T. Wrin, Susan Little, Neil T. Parkin, Jeannette Whitcomb +1 more | 2017-12-12 |
| 9581595 | Compositions and methods for determining whether a subject would benefit from co-receptor inhibitor therapy | Wei Huang, Signe Fransen, Jonathan Toma, Jeannette Whitcomb | 2017-02-28 |
| 9175355 | Methods for determining the presence of antibodies blocking viral infection | Douglas Richman, Mary T. Wrin, Susan Little, Neil T. Parkin, Jeannette Whitcomb +1 more | 2015-11-03 |
| 8603736 | Compositions and methods for determining resistance to inhibitors of virus entry using recombinant virus assays | — | 2013-12-10 |
| 7993824 | Compositions and methods for determining the susceptibility of a pathogenic virus to protease inhibitors | Colombe Chappey, Neil T. Parkin | 2011-08-09 |
| 7553618 | Method for determining human immunodeficiciency virus type 1 (HIV-1) hypersusceptibility to the protease inhibitor amprenavir | Neil T. Parkin, Ellen Paxinos, Colombe Chappey, Mary T. Wrin, Andrea Gamarnik | 2009-06-30 |
| 7384734 | Compositions and methods for determining the susceptibility of a pathogenic virus to protease inhibitors | Neil T. Parkin, Colombe Chappey | 2008-06-10 |
| 7279279 | Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening | Daniel J. Capon | 2007-10-09 |
| 7247439 | Method of evaluating a patient antibody response to envelope proteins of a virus | Douglas Richman, Mary T. Wrin, Susan Little, Neil T. Parkin, Jeannette Whitcomb +1 more | 2007-07-24 |
| 7235356 | Methods of evaluating cell surface receptor binding of a patient derived population of viral envelope protein constructs | Neil T. Parkin, Jeanette Whitcomb, Wei Huang | 2007-06-26 |
| 7169551 | Methods of evaluating viral entry inhibitors using patient derived envelope protein constructs | Neil T. Parkin, Jeanette Whitcomb, Wei Huang | 2007-01-30 |
| 7097970 | Methods of evaluating viral entry inhibitors using patient derived envelope protein constructs | Neil T. Parkin, Jeanette Whitcomb, Wei Huang | 2006-08-29 |
| 6942969 | Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening | Daniel J. Capon | 2005-09-13 |
| 6489098 | Means and methods for monitoring nucleoside reverse transcriptase inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS | Jeannette Whitcomb | 2002-12-03 |
| 6242187 | Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening | Daniel J. Capon | 2001-06-05 |
| 5837464 | Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening | Daniel J. Capon | 1998-11-17 |